These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 25012748

  • 1. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
    Keskin D, Keskin G, Inal A, Ozışık L.
    Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
    [Abstract] [Full Text] [Related]

  • 2. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdogan A, Sengul A, Dinc A.
    Clin Exp Rheumatol; 2007 Aug; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Homocysteine: an activity marker in Behçet's disease?
    Sarican T, Ayabakan H, Turkmen S, Kalaslioglu V, Baran F, Yenice N.
    J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
    [Abstract] [Full Text] [Related]

  • 5. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M, Karatay S, Yildirim K, Kadi M, Erdem T, Senel K.
    Cell Biochem Funct; 2006 Feb; 24(4):353-6. PubMed ID: 15898123
    [Abstract] [Full Text] [Related]

  • 6. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
    Özden MG, Caycı YT, Tekin H, Çoban AY, Aydın F, Sentürk N, Bek Y, Cantürk T, Turanlı AY.
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
    Hamzaoui K, Ben Dhifallah I, Karray E, Sassi FH, Hamzaoui A.
    Clin Exp Rheumatol; 2010 Oct; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
    [Abstract] [Full Text] [Related]

  • 9. Increased serum ferritin levels in active Behçet's disease.
    Odabas AR, Karakuzu A, Cetinkaya R, Selcuk Y, Keles S, Bilen H.
    Int J Clin Pract; 2002 May; 56(4):310-1. PubMed ID: 12074217
    [Abstract] [Full Text] [Related]

  • 10. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.
    Duygulu F, Evereklioglu C, Calis M, Borlu M, Cekmen M, Ascioglu O.
    Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528
    [Abstract] [Full Text] [Related]

  • 11. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
    Aki T, Karincaoglu Y, Seyhan M, Batcioglu K.
    Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
    [Abstract] [Full Text] [Related]

  • 12. Plasma homocysteine level and uveitis in Behçet's disease.
    Okka M, Oztürk M, Kockar MC, Bavbek N, Rasier Y, Gunduz K.
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):931-4. PubMed ID: 12455183
    [Abstract] [Full Text] [Related]

  • 13. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA, Kiziltunç A, Taysi S, Akdemir S, Gündoğdu M.
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [Abstract] [Full Text] [Related]

  • 14. Serum levels of GRO-α are elevated in association with disease activity in patients with Behçet's disease.
    Kato Y, Yamamoto T.
    Int J Dermatol; 2012 Mar; 51(3):286-9. PubMed ID: 22348563
    [Abstract] [Full Text] [Related]

  • 15. Fractalkine (CX3CL1) levels in patients with Behçet's disease and neuro-Behçet's disease.
    Ceyla I, Tuba TK, Adisen E, Banu O, Isil F, Ali GM, Turgut I, Banu B.
    J Neurol Sci; 2012 Apr 15; 315(1-2):120-2. PubMed ID: 22177089
    [Abstract] [Full Text] [Related]

  • 16. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
    Bozoglu E, Dinc A, Erdem H, Pay S, Simsek I, Kocar IH.
    Clin Exp Rheumatol; 2005 Apr 15; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
    [Abstract] [Full Text] [Related]

  • 17. Lipid peroxidation and homocysteine levels in Behçet's disease.
    Mungan AG, Can M, Açikgöz S, Eştürk E, Altinyazar C.
    Clin Chem Lab Med; 2006 Apr 15; 44(9):1115-8. PubMed ID: 16958606
    [Abstract] [Full Text] [Related]

  • 18. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
    Atıl A, Deniz A.
    Vascular; 2018 Aug 15; 26(4):378-386. PubMed ID: 29360007
    [Abstract] [Full Text] [Related]

  • 19. Adiponectin levels, insulin resistance and their relationship with serum levels of inflammatory cytokines in patients with Behçet's disease.
    Şahin E, Karaman G, Uslu M, Karul A, Şendur N, Şavk E.
    J Eur Acad Dermatol Venereol; 2012 Dec 15; 26(12):1498-502. PubMed ID: 22035239
    [Abstract] [Full Text] [Related]

  • 20. Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.
    Yuksel M, Yildiz A, Oylumlu M, Turkcu FM, Bilik MZ, Ekinci A, Elbey B, Tekbas E, Alan S.
    Clin Rheumatol; 2016 Mar 15; 35(3):701-8. PubMed ID: 25744156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.